Fulcrum Asset Management’s Eli Lilly LLY Stock Holding History

Fulcrum Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.7M	Buy	+8,675	New	+$8.86M	1.06%	15

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fulcrum Asset Management's LLY Position: Q2 2026 in Review

Fulcrum Asset Management opened a new position in Eli Lilly (LLY) in Q2 2026: 8,675 shares worth $10.7M. The stake represents 1.06% of the portfolio and ranks #15 among its holdings.

4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Fulcrum Asset Management held 8,675 shares of Eli Lilly worth $10.7M as of Q2 2026.
Eli Lilly was a new Fulcrum Asset Management position in Q2 2026.
Eli Lilly made up 1.06% of Fulcrum Asset Management's portfolio in Q2 2026, its #15 holding.
4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fulcrum Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.